Oncology & Cancer

Drug combo breaks down cancer resistance to immunotherapy

Immunotherapy is a way of treating cancer by reprogramming the patient's immune system to attack their tumor. This cutting-edge approach has significantly impacted the treatment of cancer patients, and already boasts cases ...

Diseases, Conditions, Syndromes

Researcher's surprising finding could lead to glanders vaccine

(Medical Xpress)—Apichai Tuanyok dedicated several years to working on a bacterial pathogen in Canada, but his breakthrough occurred in Flagstaff with an unexpected finding on a routine lab report.

Oncology & Cancer

The protein behind immunotherapy resistance

Immunotherapy is a cutting-edge approach to treating cancer by turning the patient's own immune system against their tumor. Our increasing knowledge of the mechanisms by which the body regulates immune responses has been ...

Arthritis & Rheumatism

Rheumatologist recommends patients receive pneumococcal vaccine

Patients with rheumatoid arthritis, lupus, and other rheumatic conditions are more at risk for complications and death from pneumonia, meningitis, and other bacterial infections, yet most have not been vaccinated against ...

Oncology & Cancer

Immunotherapy to shrink treatment-resistant cancer tumors

Advancements in cancer research and treatment have resulted in great improvements in survival rates—today, there are almost 17 million people in the United States alone who have survived their diagnosis because of the physicians ...

Medical research

New hope for kidney cancer treatment using existing drugs

The most comprehensive study of kidney cancer at single-cell level has discovered a potential drug target to treat renal cell carcinoma, a cancer with a high mortality rate that is hard to detect. Researchers from the Wellcome ...

Oncology & Cancer

New injectable gel offers promise for tough-to-treat brain tumors

Like the hardiest weed, glioblastoma almost always springs back—usually within months after a patient's initial brain tumor is surgically removed. That is why survival rates for this cancer are just 25 percent at one year ...

Diseases, Conditions, Syndromes

Has Delta killed the herd immunity dream?

As the Delta variant continues its global surge, experts are questioning whether the long-held goal of achieving herd immunity from COVID-19 through vaccination is still viable.

page 2 from 17